We will delve into the latest advancements and clinical applications of neoadjuvant immunotherapy in colorectal cancer, with a focus on its integration into surgical practice. The focus will be on the latest clinical evidence of the use of immunotherapy in the neoadjuvant therapy for both dMMR/MSI-H and pMMR/MSS colorectal cancer patients.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 9525 West Bryn Mawr
Pricing
CME included with membership · $60–595/yr
| Active (US Physicians) | $595/yr |
| Active International (High-Income Countries) | $345/yr |
| Active International (Middle/Low-Income Countries) | $207/yr |
| Advanced Practice Provider / Associate | $100/yr |
| Candidate – Fellow-in-Training | $150/yr |
| Candidate – Post-Fellowship | $275/yr |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
-
ReleasedNov 4, 2025
-
Last day to claim creditNov 5, 2026 4 weeks left
-
Learner’s Digest International (TM) Neoadjuvant Endocrine Therapy in Breast Cancer
-
College of American Pathologists Breast: A Roadmap Towards the Perfect Pathology Report of Post-Neoadjuvant Therapy Resections
-
Answers in CME Inc. (AiCME) From Surgery to Systemic Therapy: A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy
